-
Mashup Score: 0
Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announces the successful closing of a $60 mi …
Source: www.newswire.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4Cancer centers launch Cancer AI Alliance to unlock discoveries, transform care using cancer data and applied AI - 2 month(s) ago
AWS, Deloitte, Microsoft and NVIDIA bring the latest in AI technology, coordination, and compute to the alliance and back with initial funding
Source: www.newswire.comCategories: General Medicine News, Oncologists1Tweet-
Cancer centers launch Cancer AI Alliance to unlock discoveries, transform care using cancer data and applied AI https://t.co/36yPA8YBQ3
-
-
Mashup Score: 16The Transmitter Partners With World Wide Neuro and Brain Inspired, Building on Mission to Inform, Connect Neuroscience Community - 3 month(s) ago
The Transmitter, a leading neuroscience publication, has partnered with World Wide Neuro and Brain Inspired to further its commitment to supportin …
Source: www.newswire.comCategories: General Medicine News, General HCPsTweet-
Thrilled to announce two new @_TheTransmitter partnerships with @pgmid @TPVogels @BozelosP @worldwideneuro, building on our mission to inform and connect the neuroscience community https://t.co/74pXcJ1pWi
-
-
Mashup Score: 0May Revision: Multi-Year Continuous Medi-Cal Coverage for Young Children Not Funded - 7 month(s) ago
Tens of Thousands of California Children’s Medi-Cal Coverage Not Preserved
Source: www.newswire.comCategories: General Medicine News, PediatricsTweet-
May Revision: Multi-Year Continuous Medi-Cal Coverage for Young Children Not Funded | Newswire https://t.co/lay9zjd4us
-
-
Mashup Score: 3ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma - 8 month(s) ago
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti as a third-line treatment for multiple myeloma.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
ASTCT supports the decision by the @US_FDA to grant #multiplemyeloma patients earlier access to two #CARTcell therapies. This approval allows for greater access to life-saving treatments. Read the press release: https://t.co/3erfnEdOzy #MMsm https://t.co/avTkUWgQ5T
-
-
Mashup Score: 9ASTCT Supports the FDA’s Approval of Earlier Use of CAR T-Cell Therapy for Multiple Myeloma - 8 month(s) ago
The Food and Drug Administration approves CAR T-Cell therapy Abecma as a second-line treatment and the CAR T-Cell therapy Carvykti as a third-line treatment for multiple myeloma.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
ASTCT supports the decision by the @US_FDA to grant #multiplemyeloma patients earlier access to two #CARTcell therapies. This approval allows for greater access to life-saving treatments. Read the press release: https://t.co/3erfnEdOzy #MMsm https://t.co/avTkUWgQ5T
-
-
Mashup Score: 4The Centers for Medicare & Medicaid Services Revise National Coverage Determination for Stem Cell Transplantation - 9 month(s) ago
The Centers for Medicare & Medicaid Services revise the National Coverage Determination of allogeneic hematopoietic stem cell transplantation (HSCT) for individuals with myelodysplastic syndromes (MDS) based on requests from ASH, ASTCT, NMDP, and CIBMTR.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
ASTCT is encouraged by the @CMSGov decision to revise the National Coverage Determination of #alloHSCT, based on our recommendations. The revision offers full coverage to some MDS patients & is a step forward in providing life-saving treatment access. https://t.co/ozlYFBIbg3 https://t.co/bo4FiGaiA8
-
-
Mashup Score: 1ASCP Partners With the Lamy Center at the University of Maryland School of Pharmacy to Spread the Adoption of Age-Friendly Health Systems - 9 month(s) ago
As the older adult population continues to grow exponentially, the American Society of Consultant Pharmacists (ASCP) and The Peter Lamy Center on …
Source: www.newswire.comCategories: General Medicine News, Hem/OncsTweet-
ASCP Partners With the Lamy Center at the University of Maryland School of Pharmacy to Spread the Adoption of Age-Friendly Health Systems https://t.co/LL7WuFxYs8
-
-
Mashup Score: 12American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award - 10 month(s) ago
The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
Anchor @RobinRoberts of @GMA, is the 2024 ASTCT Public Service Award Recipient 🏆This award is in recognition of Robins' special service to the patients and families ASTCT serves. Read the full press release: https://t.co/5jgk0PZb4t https://t.co/v6N6Oq8Rik
-
-
Mashup Score: 0American Society for Transplantation and Cellular Therapy Awards Robin Roberts With the 2024 Public Service Award - 10 month(s) ago
The annual award honors Roberts’ special service to the patients and families that are served by the ASTCT community.
Source: www.newswire.comCategories: General Medicine News, Onc News and JournalsTweet-
Anchor @RobinRoberts of @GMA, is the 2024 ASTCT Public Service Award Recipient 🏆This award is in recognition of Robins' special service to the patients and families ASTCT serves. Read the full press release: https://t.co/5jgk0PZb4t https://t.co/v6N6Oq8Rik
-
.@BetaBionics Announces Closing of a $60 Million Series E Financing | #diabetes #insulinpump https://t.co/LVdQjtvCT8